相似文献
1
Serum microRNAs: A new diagnostic method for colorectal cancer.
Biomed Rep. 2013 Jul;1(4):495-498. doi: 10.3892/br.2013.109. Epub 2013 May 20.
2
microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Oncol Rep. 2013 Jul;30(1):320-6. doi: 10.3892/or.2013.2475. Epub 2013 May 15.
3
Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Ann Oncol. 2016 Oct;27(10):1879-86. doi: 10.1093/annonc/mdw279. Epub 2016 Aug 8.
4
Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Cancer. 2018 Feb 15;124(4):785-796. doi: 10.1002/cncr.31062. Epub 2017 Nov 7.
5
MicroRNAs that regulate PTEN as potential biomarkers in colorectal cancer: a systematic review.
J Cancer Res Clin Oncol. 2020 Apr;146(4):809-820. doi: 10.1007/s00432-020-03172-3. Epub 2020 Mar 7.
6
A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Life Sci. 2020 Oct 1;258:118226. doi: 10.1016/j.lfs.2020.118226. Epub 2020 Aug 6.
7
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
Int J Cancer. 2010 Jul 1;127(1):118-26. doi: 10.1002/ijc.25007.
8
Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.
Cancer Epidemiol. 2012 Feb;36(1):e61-7. doi: 10.1016/j.canep.2011.05.002. Epub 2011 Oct 21.
9
Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
Mol Cell Biochem. 2019 Apr;454(1-2):177-189. doi: 10.1007/s11010-018-3462-1. Epub 2018 Oct 24.
10
Fecal miR-29a and miR-224 as the noninvasive biomarkers for colorectal cancer.
Cancer Biomark. 2016;16(2):259-64. doi: 10.3233/CBM-150563.
引用本文的文献
1
miR-601 inhibits proliferation, migration and invasion of prostate cancer stem cells by targeting KRT5 to inactivate the Wnt signaling pathway.
Int J Clin Exp Pathol. 2019 Dec 1;12(12):4361-4379. eCollection 2019.
2
The Differential DNA Hypermethylation Patterns of microRNA-137 and microRNA-342 Locus in Early Colorectal Lesions and Tumours.
Biomolecules. 2019 Sep 21;9(10):519. doi: 10.3390/biom9100519.
3
Exosome: Function and Role in Cancer Metastasis and Drug Resistance.
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818763450. doi: 10.1177/1533033818763450.
4
MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling.
J Exp Clin Cancer Res. 2018 Apr 16;37(1):83. doi: 10.1186/s13046-018-0757-8.
5
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.
Cell Death Differ. 2018 Jul;25(7):1224-1238. doi: 10.1038/s41418-018-0088-5. Epub 2018 Mar 22.
6
Urine miR-21-5p as a potential non-invasive biomarker for gastric cancer.
Oncotarget. 2017 Apr 7;8(34):56389-56397. doi: 10.18632/oncotarget.16916. eCollection 2017 Aug 22.
7
MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis.
Cell Death Dis. 2016 Oct 13;7(10):e2413. doi: 10.1038/cddis.2016.306.
8
Survival Benefit and Safety of Bevacizumab in Combination with Erlotinib as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: A Meta-Analysis.
Clin Drug Investig. 2017 Feb;37(2):155-165. doi: 10.1007/s40261-016-0465-0.
9
Extracellular miRNA-21 as a novel biomarker in glioma: Evidence from meta-analysis, clinical validation and experimental investigations.
Oncotarget. 2016 Jun 7;7(23):33994-4010. doi: 10.18632/oncotarget.9188.
10
miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3.
Int J Clin Exp Pathol. 2015 Oct 1;8(10):12853-60. eCollection 2015.
本文引用的文献
1
Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
PLoS One. 2012;7(9):e44398. doi: 10.1371/journal.pone.0044398. Epub 2012 Sep 6.
2
Plasma miR-21: a potential diagnostic marker of colorectal cancer.
Ann Surg. 2012 Sep;256(3):544-51. doi: 10.1097/SLA.0b013e318265bd6f.
3
The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors.
J Cancer Res Clin Oncol. 2012 Oct;138(10):1659-66. doi: 10.1007/s00432-012-1244-9. Epub 2012 May 26.
4
MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Hepatology. 2012 Jun;55(6):1852-62. doi: 10.1002/hep.25576.
5
Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.
Cancer Epidemiol. 2012 Feb;36(1):e61-7. doi: 10.1016/j.canep.2011.05.002. Epub 2011 Oct 21.
6
miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
Mol Cancer Res. 2011 Jul;9(7):824-33. doi: 10.1158/1541-7786.MCR-10-0529. Epub 2011 May 31.
7
Clinical application of tumour markers: a review.
East Afr Med J. 2009 Dec;86(12 Suppl):S76-83. doi: 10.4314/eamj.v86i12.62909.
8
MicroRNA signatures: novel biomarker for colorectal cancer?
Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1272-86. doi: 10.1158/1055-9965.EPI-11-0035. Epub 2011 May 6.
9
Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis.
PLoS One. 2011 Mar 17;6(3):e17745. doi: 10.1371/journal.pone.0017745.
10
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
Zotero 插件